AtriCure, Inc. — Director's Dealing 2017

Dec 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-11-30

Reporting Person: Wade M. Andrew (SVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-30	Common Stock	M	2000	$11.65	Acquired	163950	Direct
2017-11-30	Common Stock	S	2000	$18.41	Disposed	161950	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-30	Stock Option (right to buy)	$11.65	M	2000	Disposed	2017-12-05	Common Stock (2000)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $18.40 to $18.50 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This option was granted on December 5, 2007 and is exercisable as to 25% of the shares upon the one year anniversary of the date of the grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.